aspirin has been researched along with 2019 Novel Coronavirus Disease in 129 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In older patients hospitalized for SARS-CoV-2 pneumonia, we aimed to investigate the association between aspirin use before admission and the risk of in-hospital all-cause mortality." | 8.12 | Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia. ( Bermejo, M; Bouiller, K; Fèvre, A; Gilis, M; Hacquin, A; Hoefler, F; Laborde, C; Manckoundia, P; Mendes, A; Prendki, V; Putot, A; Sanchez, S; Serratrice, C; Sullerot, C, 2022) |
| "Low dose aspirin improves survival rates in coronavirus disease 2019 associated mucormycosis." | 8.12 | Decreased mortality in coronavirus disease 2019 associated mucormycosis with aspirin use: a retrospective cohort study. ( Adhikari, A; Biswas, R; Chadaram, S; Chakraborty, S; Chenniappan, S; Chithambaram, KS; Das, KK; Hallur, VK; Karakkandy, V; Mishra, A; Mittal, Y; Nayak, A; Parida, PK; Pradhan, P; Preetam, C; Samal, DK; Sarkar, S; Shah, A; Shaikh, Z; Sharma, P; Swarup, A; Veeti, AK, 2022) |
| "To determine whether pre-hospitalization use of aspirin is associated with all-cause mortality in coronavirus disease 2019 (COVID-19) patients with coronary artery disease (CAD)." | 8.02 | Mortality and pre-hospitalization use of low-dose aspirin in COVID-19 patients with coronary artery disease. ( Chen, C; Chen, P; Li, H; Wang, DW; Wang, F; Yuan, S, 2021) |
| "This is a case report of central retinal vein occlusion (CRVO) associated with COVID-19 treated with oral aspirin therapy." | 8.02 | COVID-19-associated central retinal vein occlusion treated with oral aspirin. ( Agrawal, S; Pereira, A; Reddy, NG; Venkatesh, R, 2021) |
| "Aspirin was administered to all patients once a day." | 5.56 | Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action. ( Frigieri, FC; Gianesello, L; Meconi, T; Pavoni, V; Pazzi, M; Stera, C, 2020) |
| "The authors recommend a low-dose aspirin regimen for primary prevention of arterial thromboembolism in patients aged 40-70 years who are at high atherosclerotic cardiovascular disease risk, or an intermediate risk with a risk-enhancer and have a low risk of bleeding." | 5.12 | Rationales and uncertainties for aspirin use in COVID-19: a narrative review. ( Aiash, H; Amin, H; Darling, E; Goweda, RA; Habeb, H; Ismail, M; Joudeh, AI; Merrell, E; Nieman, GF; Riley, JB; Sayed Ahmed, HA; Shawkat, A; Shehata, MH, 2021) |
| " The aspirin is useful to reduce mortality of serious patients with acute respiratory distress syndrome without COVID-19." | 5.12 | Use of aspirin in reduction of mortality of COVID-19 patients: A meta-analysis. ( Kumar, A; Srivastava, R, 2021) |
| " Outcomes included 6 clinical quality measures of being up to date for colorectal cancer screening, cervical cancer screening, tobacco screening and cessation counseling, BMI screening and follow-up, depression screening and follow-up, and aspirin use for ischemic vascular disease." | 4.31 | The First Year of the COVID-19 Pandemic: Changes in Preventive Services in Community Health Centers. ( Bandi, P; Han, X; Jemal, A; Makaroff, LA; Minihan, AK; Star, J, 2023) |
| "We describe our experience running the investigator-initiated phase III randomized, fully accrued, Aspirin for Dukes C and high-risk Dukes B Colorectal cancer trial (ASCOLT, ClinicalTrials." | 4.31 | Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial. ( Ali, R; Chia, JWK; Day, D; Foo, EMJ; Segelov, E; Simes, J; Toh, HC, 2023) |
| " In older patients hospitalized for SARS-CoV-2 pneumonia, we aimed to investigate the association between aspirin use before admission and the risk of in-hospital all-cause mortality." | 4.12 | Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia. ( Bermejo, M; Bouiller, K; Fèvre, A; Gilis, M; Hacquin, A; Hoefler, F; Laborde, C; Manckoundia, P; Mendes, A; Prendki, V; Putot, A; Sanchez, S; Serratrice, C; Sullerot, C, 2022) |
| "Continuation of aspirin therapy during ICU stay in critically ill patients with COVID-19 who were receiving it prior to ICU admission may have a mortality benefit; nevertheless, it may be associated with an increased risk of significant bleeding." | 4.12 | Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study. ( Al Enazi, H; Al Harbi, S; Al Harthi, AF; Al Sulaiman, K; Alawad, A; Alenezi, RS; Alhuthaili, O; Aljuhani, O; Almazrou, S; Alotaibi, R; Alqahtani, RA; Alshehri, A; Alsulaiman, T; Altebainawi, AF; Bin Saleh, K; Gramish, J; Hafidh, A; Hussain, S; Kensara, R; Korayem, GB; Vishwakarma, R, 2022) |
| "Low dose aspirin improves survival rates in coronavirus disease 2019 associated mucormycosis." | 4.12 | Decreased mortality in coronavirus disease 2019 associated mucormycosis with aspirin use: a retrospective cohort study. ( Adhikari, A; Biswas, R; Chadaram, S; Chakraborty, S; Chenniappan, S; Chithambaram, KS; Das, KK; Hallur, VK; Karakkandy, V; Mishra, A; Mittal, Y; Nayak, A; Parida, PK; Pradhan, P; Preetam, C; Samal, DK; Sarkar, S; Shah, A; Shaikh, Z; Sharma, P; Swarup, A; Veeti, AK, 2022) |
| "To determine whether pre-hospitalization use of aspirin is associated with all-cause mortality in coronavirus disease 2019 (COVID-19) patients with coronary artery disease (CAD)." | 4.02 | Mortality and pre-hospitalization use of low-dose aspirin in COVID-19 patients with coronary artery disease. ( Chen, C; Chen, P; Li, H; Wang, DW; Wang, F; Yuan, S, 2021) |
| "Acetylsalicylic acid (aspirin) is commonly used for primary and secondary prevention of cardiovascular diseases." | 4.02 | The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID-19 infection. ( Avramovich, E; Frenkel-Morgenstern, M; Golan-Cohen, A; Gorohovski, A; Green, I; Magen, E; Merzon, E; Vinker, S, 2021) |
| "This is a case report of central retinal vein occlusion (CRVO) associated with COVID-19 treated with oral aspirin therapy." | 4.02 | COVID-19-associated central retinal vein occlusion treated with oral aspirin. ( Agrawal, S; Pereira, A; Reddy, NG; Venkatesh, R, 2021) |
| "Aspirin was well tolerated but did not improve OI or other physiological outcomes; a larger trial is not feasible in its current design." | 3.11 | Aspirin as a Treatment for ARDS: A Randomized, Placebo-Controlled Clinical Trial. ( Boyle, AJ; Callaghan, K; Johnston, P; McAuley, DF; McFarland, M; McNamee, JJ; Nutt, C; O'Kane, CM; Toner, P; Trinder, J; Verghis, R, 2022) |
| "Severe coronavirus disease 2019 (COVID-19) can cause thrombotic events that lead to severe complications or death." | 3.01 | Antiplatelet agents for the treatment of adults with COVID-19. ( Andreas, M; Estcourt, LJ; Fischer, AL; Martimbianco, ALC; Messer, S; Monsef, I; Pacheco, RL; Riera, R; Skoetz, N; Stegemann, M; Weibel, S, 2023) |
| "Both hypoxemia and a prothrombotic diathesis have been associated with more severe disease and increased risk of death." | 2.94 | Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. ( Forleo, GB; Radovanovic, D; Santus, P; Viecca, M, 2020) |
| " Hence, whether ASA might be a safe and reasonable therapeutic candidate to be tested in clinical trials involving adults with COVID-19 deserves further attention." | 2.66 | Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? ( Bianconi, V; Fallarino, F; Pignatelli, P; Pirro, M; Sahebkar, A; Violi, F, 2020) |
| "Indeed, Kawasaki disease is induced by overreaction of innate cells following exposition to various viruses, including herpes viruses which trigger STING." | 2.66 | Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway? ( Berthelot, JM; Drouet, L; Lioté, F, 2020) |
| "Aspirin was given to patients with preexisting comorbidities, but it had no statistically significant impact on the outcomes of the different groups." | 1.91 | Effect of combination of prophylactic or therapeutic anticoagulation with aspirin on the outcomes of hospitalized COVID-19 patients: An observational retrospective study. ( Dimassi, H; El Hout, G; Farra, A; Fleifel, M; Franjieh, E; Harb, R; Haykal, T; Husni, R; Mahdi, A; Mina, J; Mokhbat, J; Nasr, J, 2023) |
| "Aspirin is a well-known anti-platelet drug widely used for the prevention of cardiovascular events and systematic reviews suggest a possible benefit of low-dose aspirin (LDA) use in the prevention and treatment of ARDS in patients with COVID-19 infection." | 1.91 | Low dose aspirin and clinical outcomes in patients with SARS-CoV-2 pneumonia: a propensity score-matched cohort analysis from the National SIMI‑COVID‑19 Registry. ( Cimellaro, A; Daidone, M; Dalbeni, A; Giontella, A; Pietrangelo, A; Rossi, I; Sesti, G; Susca, N; Talerico, G; Villani, R; Zaccone, V, 2023) |
| "Presently Coronavirus disease 2019 is a huge human misery that is almost unstoppable with little remedy on board." | 1.72 | Beneficial Effect of Low Dose Aspirin in Adult Patients with COVID-19: A Retrospective Observational Study in Bangladesh. ( Husain, A; Kamal, SM; Morshed, ME; Sayem, MA, 2022) |
| "The data from studies presenting cerebrovascular diseases associated with SARS-Cov-2, which constituted 0." | 1.72 | Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies? ( Ates, O; Dogan, M; Ersoz, E; Hacioglu Kasim, FB; Karaarslan, N; Ozbek, H; Yilmaz, I, 2022) |
| "When corrected for comorbid illnesses, COPD was associated with more severe disease but not with increased ICU admission, mechanical ventilation, or in-hospital mortality rates." | 1.72 | Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis. ( Barjaktarevic, I; Buhr, RG; Fulcher, JA; Markovic, D; Shover, CM; Tashkin, DP; Toppen, W; Yan, P, 2022) |
| "Patients with coronavirus disease 2019 (COVID-19) from novel coronavirus (SARS-CoV-2) infection may present with immune thrombocytopenia (ITP)." | 1.62 | Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series. ( Grimes, AB; Kok, EY; Muscal, E; Sexson Tejtel, SK; Srivaths, L; Vogel, TP, 2021) |
| "Aspirin was commonly recommended for mild cases, whereas heparin or low molecular weight heparin were to be used primarily in severe cases." | 1.62 | Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management. ( Abuali, M; Ang, JY; Ballan, W; Basu, SK; Campbell, MJ; Chikkabyrappa, SM; Choueiter, NF; Clouser, KN; Corwin, D; Dove, ML; Edwards, A; Gertz, SJ; Ghassemzadeh, R; Jaggi, P; Jarrah, RJ; Katz, SE; Kelleman, M; Knutson, SM; Kuebler, JD; Lighter, J; Mikesell, C; Mongkolrattanothai, K; Morton, T; Nakra, NA; Olivero, R; Osborne, CM; Oster, ME; Panesar, LE; Parsons, S; Patel, RM; Schuette, J; Thacker, D; Tremoulet, AH; Vidwan, NK, 2021) |
| "As the number of coronavirus disease 2019 (COVID-19) cases increases globally, more cases of a rare COVID-19-associated disease process are being identified in the pediatric population." | 1.62 | Multisystem Inflammatory Syndrome in Children. ( Cassidy-Smith, T; Kothari, P; Tabaac, S, 2021) |
| "Patients with coronavirus disease 2019 (COVID-19) exhibit high thrombotic risk." | 1.62 | Pre-admission acetylsalicylic acid therapy and impact on in-hospital outcome in COVID-19 patients: The ASA-CARE study. ( Bandera, F; Battista, A; Battista, F; Battista, RA; Biagi, A; Comastri, G; Godino, C; Guazzi, M; Malagoli, A; Margonato, A; Marrocco-Trischitta, MM; Monello, A; Poletti, E; Rossi, L; Sisinni, A; Sticozzi, C; Vergara, P; Zanni, A, 2021) |
| "Myocarditis has been reported as a possible and rare adverse consequence of different vaccines, and its clinical presentation can range from influenza-like symptoms to acute heart failure." | 1.62 | Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction? ( Ascenti, G; Blandino, A; Booz, C; Carerj, ML; Cattafi, A; Cicero, G; D'Angelo, T; Mazziotti, S, 2021) |
| "Aspirin exposure was not associated with COVID-19-related complications and mortality in COVID-19 patients." | 1.62 | Effect of aspirin on coronavirus disease 2019: A nationwide case-control study in South Korea. ( Lee, JH; Noh, MG; Park, H; Seo, J; Son, M; Yang, S, 2021) |
| "In patients with STEMI, fibrinolysis achieved a comparable in-hospital and 30-day primary composite end point, as compared with those who received PPCI during the COVID-19 pandemic." | 1.56 | Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic. ( Huang, Z; Lin, Y; Su, H; Wang, N; Zhang, M, 2020) |
| "Aspirin was administered to all patients once a day." | 1.56 | Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action. ( Frigieri, FC; Gianesello, L; Meconi, T; Pavoni, V; Pazzi, M; Stera, C, 2020) |
| "His course was complicated by cytokine storm and COVID-19-associated coagulopathy." | 1.56 | Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device. ( Estep, J; Hodges, K; Hsich, E; Insler, J; Insler, S; Mubashir, M; Soltesz, E; Tong, M, 2020) |
| "BACKGROUND Coronavirus disease 2019 (COVID-19) infection commonly presents as fever, cough, and shortness of breath in adults." | 1.56 | Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2. ( Bauerfeld, C; Garcia, RU; Heidemann, SM; Martin, A; Sarnaik, AP; Tilford, B; Yagiela, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 129 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ankola, AA | 1 |
| Bradford, VR | 1 |
| Newburger, JW | 1 |
| Emani, S | 1 |
| Dionne, A | 1 |
| Friedman, K | 1 |
| Son, MB | 1 |
| Henderson, LA | 1 |
| Lee, PY | 1 |
| Hellinger, A | 1 |
| Hawkins, B | 1 |
| Ventresco, C | 1 |
| Esteso, P | 1 |
| VanderPluym, CJ | 1 |
| Kow, CS | 3 |
| Ramachandram, DS | 2 |
| Hasan, SS | 3 |
| Kim, I | 1 |
| Yoon, S | 1 |
| Kim, M | 1 |
| Lee, H | 1 |
| Park, S | 1 |
| Kim, W | 1 |
| Lee, S | 1 |
| Sakaguchi, S | 1 |
| Fujimoto, N | 1 |
| Ichikawa, K | 1 |
| Izumi, D | 1 |
| Katsuta, K | 1 |
| Takafuji, M | 1 |
| Imanaka-Yoshida, K | 1 |
| Dohi, K | 1 |
| Sisinni, A | 1 |
| Rossi, L | 1 |
| Battista, A | 1 |
| Poletti, E | 1 |
| Battista, F | 1 |
| Battista, RA | 1 |
| Malagoli, A | 1 |
| Biagi, A | 1 |
| Zanni, A | 1 |
| Sticozzi, C | 1 |
| Comastri, G | 1 |
| Marrocco-Trischitta, MM | 1 |
| Monello, A | 1 |
| Margonato, A | 1 |
| Bandera, F | 1 |
| Vergara, P | 1 |
| Guazzi, M | 1 |
| Godino, C | 1 |
| Connors, JM | 1 |
| Brooks, MM | 1 |
| Sciurba, FC | 1 |
| Krishnan, JA | 1 |
| Bledsoe, JR | 1 |
| Kindzelski, A | 1 |
| Baucom, AL | 1 |
| Kirwan, BA | 1 |
| Eng, H | 1 |
| Martin, D | 1 |
| Zaharris, E | 1 |
| Everett, B | 1 |
| Castro, L | 1 |
| Shapiro, NL | 1 |
| Lin, JY | 1 |
| Hou, PC | 1 |
| Pepine, CJ | 1 |
| Handberg, E | 1 |
| Haight, DO | 1 |
| Wilson, JW | 1 |
| Majercik, S | 1 |
| Fu, Z | 1 |
| Zhong, Y | 1 |
| Venugopal, V | 1 |
| Beach, S | 1 |
| Wisniewski, S | 1 |
| Ridker, PM | 1 |
| Voruganti, D | 1 |
| Bassareo, PP | 1 |
| Calcaterra, G | 1 |
| Mehta, JL | 2 |
| Tantry, US | 2 |
| Bliden, KP | 3 |
| Gurbel, PA | 3 |
| Srour, AM | 1 |
| Panda, SS | 1 |
| Mostafa, A | 1 |
| Fayad, W | 1 |
| El-Manawaty, MA | 1 |
| A F Soliman, A | 1 |
| Moatasim, Y | 1 |
| El Taweel, A | 1 |
| Abdelhameed, MF | 1 |
| Bekheit, MS | 1 |
| Ali, MA | 1 |
| Girgis, AS | 1 |
| Toner, P | 1 |
| Boyle, AJ | 1 |
| McNamee, JJ | 1 |
| Callaghan, K | 1 |
| Nutt, C | 1 |
| Johnston, P | 1 |
| Trinder, J | 1 |
| McFarland, M | 1 |
| Verghis, R | 1 |
| McAuley, DF | 2 |
| O'Kane, CM | 1 |
| Tafazoli, A | 1 |
| Anil Kumar, S | 1 |
| Othman, M | 1 |
| Hantoushzadeh, S | 1 |
| Saleh, M | 1 |
| Nouri, B | 1 |
| Panahi, Z | 1 |
| Rigual, R | 1 |
| Ruiz-Ares, G | 1 |
| Rodriguez-Pardo, J | 1 |
| Fernández-Prieto, A | 1 |
| Navia, P | 1 |
| Novo, JR | 1 |
| Alonso de Leciñana, M | 1 |
| Alonso-Singer, P | 1 |
| Fuentes, B | 1 |
| Díez-Tejedor, E | 1 |
| Fazio, S | 1 |
| Bellavite, P | 1 |
| Zanolin, E | 1 |
| McCullough, PA | 1 |
| Pandolfi, S | 1 |
| Affuso, F | 1 |
| Jayaram, A | 1 |
| Buhimschi, IA | 1 |
| Buhimschi, CS | 1 |
| Sullerot, C | 1 |
| Bouiller, K | 1 |
| Laborde, C | 1 |
| Gilis, M | 1 |
| Fèvre, A | 1 |
| Hacquin, A | 1 |
| Manckoundia, P | 1 |
| Hoefler, F | 1 |
| Bermejo, M | 1 |
| Mendes, A | 1 |
| Serratrice, C | 1 |
| Prendki, V | 1 |
| Sanchez, S | 1 |
| Putot, A | 1 |
| Husain, A | 1 |
| Sayem, MA | 1 |
| Kamal, SM | 1 |
| Morshed, ME | 1 |
| Nimer, RM | 1 |
| Khabour, OF | 1 |
| Swedan, SF | 1 |
| Kofahi, HM | 1 |
| Zaid, Y | 1 |
| Lahlimi, Q | 1 |
| Khalki, L | 1 |
| Zaid, N | 1 |
| Oudghiri, M | 1 |
| Cheikh, A | 1 |
| Naya, A | 1 |
| Merhi, Y | 1 |
| Guessous, F | 1 |
| Bradbury, CA | 1 |
| Lawler, PR | 1 |
| Stanworth, SJ | 1 |
| McVerry, BJ | 1 |
| McQuilten, Z | 1 |
| Higgins, AM | 1 |
| Mouncey, PR | 1 |
| Al-Beidh, F | 1 |
| Rowan, KM | 1 |
| Berry, LR | 1 |
| Lorenzi, E | 1 |
| Zarychanski, R | 1 |
| Arabi, YM | 1 |
| Annane, D | 1 |
| Beane, A | 1 |
| van Bentum-Puijk, W | 1 |
| Bhimani, Z | 1 |
| Bihari, S | 1 |
| Bonten, MJM | 1 |
| Brunkhorst, FM | 1 |
| Buzgau, A | 1 |
| Buxton, M | 1 |
| Carrier, M | 1 |
| Cheng, AC | 1 |
| Cove, M | 1 |
| Detry, MA | 1 |
| Estcourt, LJ | 2 |
| Fitzgerald, M | 1 |
| Girard, TD | 1 |
| Goligher, EC | 1 |
| Goossens, H | 1 |
| Haniffa, R | 1 |
| Hills, T | 1 |
| Huang, DT | 1 |
| Horvat, CM | 1 |
| Hunt, BJ | 1 |
| Ichihara, N | 1 |
| Lamontagne, F | 1 |
| Leavis, HL | 1 |
| Linstrum, KM | 1 |
| Litton, E | 1 |
| Marshall, JC | 1 |
| McGlothlin, A | 1 |
| McGuinness, SP | 1 |
| Middeldorp, S | 1 |
| Montgomery, SK | 1 |
| Morpeth, SC | 1 |
| Murthy, S | 2 |
| Neal, MD | 1 |
| Nichol, AD | 1 |
| Parke, RL | 1 |
| Parker, JC | 1 |
| Reyes, LF | 1 |
| Saito, H | 1 |
| Santos, MS | 1 |
| Saunders, CT | 1 |
| Serpa-Neto, A | 1 |
| Seymour, CW | 1 |
| Shankar-Hari, M | 1 |
| Singh, V | 1 |
| Tolppa, T | 1 |
| Turgeon, AF | 1 |
| Turner, AM | 1 |
| van de Veerdonk, FL | 1 |
| Green, C | 1 |
| Lewis, RJ | 1 |
| Angus, DC | 1 |
| McArthur, CJ | 1 |
| Berry, S | 1 |
| Derde, LPG | 1 |
| Webb, SA | 1 |
| Gordon, AC | 1 |
| Chow, JH | 3 |
| Rahnavard, A | 1 |
| Gomberg-Maitland, M | 1 |
| Chatterjee, R | 1 |
| Patodi, P | 1 |
| Yamane, DP | 1 |
| Levine, AR | 1 |
| Davison, D | 1 |
| Hawkins, K | 1 |
| Jackson, AM | 2 |
| Quintana, MT | 1 |
| Lankford, AS | 1 |
| Keneally, RJ | 1 |
| Al-Mashat, M | 1 |
| Fisher, D | 1 |
| Williams, J | 1 |
| Berger, JS | 1 |
| Mazzeffi, MA | 3 |
| Crandall, KA | 1 |
| Al Harthi, AF | 1 |
| Aljuhani, O | 1 |
| Korayem, GB | 1 |
| Altebainawi, AF | 1 |
| Alenezi, RS | 1 |
| Al Harbi, S | 1 |
| Gramish, J | 1 |
| Kensara, R | 1 |
| Hafidh, A | 1 |
| Al Enazi, H | 1 |
| Alawad, A | 1 |
| Alotaibi, R | 1 |
| Alshehri, A | 1 |
| Alhuthaili, O | 1 |
| Vishwakarma, R | 1 |
| Bin Saleh, K | 1 |
| Alsulaiman, T | 1 |
| Alqahtani, RA | 1 |
| Hussain, S | 1 |
| Almazrou, S | 1 |
| Al Sulaiman, K | 1 |
| Feler, J | 1 |
| Chuck, C | 1 |
| Anderson, M | 1 |
| Poggi, J | 1 |
| Sweeney, J | 1 |
| Moldovan, K | 1 |
| Jayaraman, MV | 1 |
| McTaggart, R | 1 |
| Torabi, R | 1 |
| Shaikh, Z | 1 |
| Sarkar, S | 1 |
| Biswas, R | 1 |
| Adhikari, A | 1 |
| Hallur, VK | 1 |
| Parida, PK | 1 |
| Preetam, C | 1 |
| Pradhan, P | 1 |
| Samal, DK | 1 |
| Nayak, A | 1 |
| Chadaram, S | 1 |
| Das, KK | 1 |
| Chakraborty, S | 1 |
| Sharma, P | 1 |
| Veeti, AK | 1 |
| Karakkandy, V | 1 |
| Mishra, A | 1 |
| Mittal, Y | 1 |
| Chithambaram, KS | 1 |
| Swarup, A | 1 |
| Chenniappan, S | 1 |
| Shah, A | 1 |
| Santoro, F | 1 |
| Núñez-Gil, IJ | 1 |
| Vitale, E | 1 |
| Viana-Llamas, MC | 1 |
| Romero, R | 1 |
| Maroun Eid, C | 1 |
| Feltes Guzman, G | 1 |
| Becerra-Muñoz, VM | 1 |
| Fernández Rozas, I | 1 |
| Uribarri, A | 1 |
| Alfonso-Rodriguez, E | 1 |
| García Aguado, M | 1 |
| Huang, J | 1 |
| Castro Mejía, AF | 1 |
| Garcia Prieto, JF | 1 |
| Elola, J | 1 |
| Ugo, F | 1 |
| Cerrato, E | 1 |
| Signes-Costa, J | 1 |
| Raposeiras Roubin, S | 1 |
| Jativa Mendez, JL | 1 |
| Espejo Paeres, C | 1 |
| López Masjuan, A | 1 |
| Marin, F | 1 |
| Guerra, F | 1 |
| El-Battrawy, I | 1 |
| Cortese, B | 1 |
| Ramakrishna, H | 1 |
| Perez-Villacastín, J | 1 |
| Fernandez-Ortiz, A | 1 |
| Brunetti, ND | 1 |
| Ates, O | 1 |
| Yilmaz, I | 1 |
| Karaarslan, N | 1 |
| Ersoz, E | 1 |
| Hacioglu Kasim, FB | 1 |
| Dogan, M | 1 |
| Ozbek, H | 1 |
| Eman, A | 1 |
| Balaban, O | 1 |
| Süner, KÖ | 1 |
| Cırdı, Y | 1 |
| Şahin, F | 1 |
| Demir, G | 1 |
| Pekşen, Ö | 1 |
| Musmul, A | 1 |
| Erdem, AF | 1 |
| Lal, A | 2 |
| Garces, JPD | 1 |
| Bansal, V | 1 |
| Tekin, A | 1 |
| Zec, S | 1 |
| Khanna, AK | 2 |
| Warner, MA | 1 |
| Christie, AB | 1 |
| Cartin-Ceba, R | 1 |
| Banner-Goodspeed, VM | 1 |
| Armaignac, DL | 1 |
| Cheruku, SR | 1 |
| Raju, U | 1 |
| Tarabichi, Y | 1 |
| Denson, JL | 1 |
| Kumar, V | 1 |
| Walkey, A | 1 |
| Boman, K | 1 |
| Deo, N | 1 |
| Kashyap, R | 1 |
| Gajic, O | 2 |
| Morrison, FJ | 1 |
| Su, M | 1 |
| Turchin, A | 1 |
| Eikelboom, JW | 1 |
| Jolly, SS | 1 |
| Belley-Cote, EP | 1 |
| Whitlock, RP | 1 |
| Rangarajan, S | 1 |
| Xu, L | 1 |
| Heenan, L | 1 |
| Bangdiwala, SI | 1 |
| Tarhuni, WM | 1 |
| Hassany, M | 1 |
| Kontsevaya, A | 1 |
| Harper, W | 1 |
| Sharma, SK | 1 |
| Lopez-Jaramillo, P | 1 |
| Dans, AL | 1 |
| Palileo-Villanueva, LM | 1 |
| Avezum, A | 1 |
| Pais, P | 1 |
| Xavier, D | 1 |
| Felix, C | 1 |
| Yusufali, A | 1 |
| Lopes, RD | 1 |
| Berwanger, O | 1 |
| Ali, Z | 1 |
| Wasserman, S | 1 |
| Anand, SS | 1 |
| Bosch, J | 1 |
| Choudhri, S | 1 |
| Farkouh, ME | 1 |
| Loeb, M | 1 |
| Yusuf, S | 1 |
| Star, J | 1 |
| Han, X | 1 |
| Makaroff, LA | 1 |
| Minihan, AK | 1 |
| Jemal, A | 1 |
| Bandi, P | 1 |
| Khalaji, A | 3 |
| Behnoush, AH | 3 |
| Peiman, S | 3 |
| Toppen, W | 1 |
| Yan, P | 1 |
| Markovic, D | 1 |
| Shover, CM | 1 |
| Buhr, RG | 1 |
| Fulcher, JA | 1 |
| Tashkin, DP | 1 |
| Barjaktarevic, I | 1 |
| Anchidin, OI | 1 |
| Rosianu, SH | 1 |
| Nemes, A | 1 |
| Aldica, M | 1 |
| Blendea, D | 1 |
| Molnar, A | 1 |
| Moldovan, H | 1 |
| Pop, D | 1 |
| Liu, X | 1 |
| Lv, Z | 1 |
| Wang, Q | 1 |
| Yu, J | 1 |
| Wang, J | 1 |
| Zhou, Y | 2 |
| Sui, M | 1 |
| Hao, C | 1 |
| Xue, D | 1 |
| Zhang, Y | 1 |
| Singla, A | 2 |
| Dadario, NB | 1 |
| Greenberg, P | 1 |
| Yan, R | 1 |
| Nanda, A | 1 |
| Boison, D | 1 |
| Malhotra, R | 1 |
| Patel, S | 1 |
| Nipun, S | 1 |
| Maninderpal, K | 1 |
| Castro, D | 1 |
| Bdiiwi, S | 1 |
| Boktor, H | 1 |
| Kyi, HH | 1 |
| Sutherland, A | 1 |
| Patrawalla, A | 1 |
| Ly, K | 1 |
| Xie, Y | 1 |
| Sonig, A | 1 |
| Khandelwal, P | 1 |
| Liu, J | 1 |
| Koziol, J | 1 |
| Finkle, D | 1 |
| Subanna, S | 1 |
| Libutti, SK | 1 |
| Schectman, JM | 1 |
| Karami, S | 1 |
| Asonye, C | 1 |
| Pinnow, E | 1 |
| Pratt, V | 1 |
| McCulley, L | 1 |
| Dwumfour, N | 1 |
| Zhou, EH | 1 |
| Lombardi, L | 1 |
| Maiorca, F | 1 |
| Marrapodi, R | 1 |
| Sabetta, A | 1 |
| Scafa, N | 1 |
| Pallucci, D | 1 |
| Miglionico, M | 1 |
| Romiti, GF | 1 |
| Corica, B | 1 |
| Piconese, S | 1 |
| Polimeni, A | 1 |
| Pulcinelli, F | 1 |
| Cangemi, R | 1 |
| Visentini, M | 1 |
| Basili, S | 1 |
| Stefanini, L | 1 |
| Gazzaniga, G | 1 |
| Tavecchia, GA | 1 |
| Bravi, F | 1 |
| Scavelli, F | 1 |
| Travi, G | 1 |
| Campo, G | 1 |
| Vandenbriele, C | 1 |
| Tritschler, T | 1 |
| Sterne, JAC | 1 |
| Morici, N | 1 |
| Batubara, AS | 1 |
| Ainousah, BE | 1 |
| Ramzy, S | 1 |
| Abdelazim, AH | 1 |
| Gamal, M | 1 |
| Tony, RM | 1 |
| Kanagaratnam, P | 1 |
| Francis, DP | 1 |
| Chamie, D | 1 |
| Coyle, C | 1 |
| Marynina, A | 1 |
| Katritsis, G | 1 |
| Paiva, P | 1 |
| Szigeti, M | 1 |
| Cole, G | 1 |
| de Andrade Nunes, D | 1 |
| Howard, J | 1 |
| Esper, R | 1 |
| Khan, M | 1 |
| More, R | 1 |
| Barreto, G | 1 |
| Meneguz-Moreno, R | 1 |
| Arnold, A | 1 |
| Nowbar, A | 1 |
| Kaura, A | 1 |
| Mariveles, M | 1 |
| March, K | 1 |
| Shah, J | 2 |
| Nijjer, S | 1 |
| Lip, GYH | 1 |
| Mills, N | 1 |
| Camm, AJ | 1 |
| Cooke, GS | 1 |
| Corbett, SJ | 1 |
| Llewelyn, MJ | 1 |
| Ghanima, W | 1 |
| Toshner, M | 1 |
| Peters, N | 1 |
| Petraco, R | 1 |
| Al-Lamee, R | 1 |
| Boshoff, ASM | 1 |
| Durkina, M | 1 |
| Malik, I | 1 |
| Ruparelia, N | 1 |
| Cornelius, V | 1 |
| Shun-Shin, M | 1 |
| Nguyen, NN | 1 |
| Dudouet, P | 1 |
| Dhiver, C | 1 |
| Gautret, P | 1 |
| Apata, J | 1 |
| Pennap, DD | 1 |
| Mosholder, AD | 1 |
| Mina, J | 1 |
| Fleifel, M | 1 |
| Haykal, T | 1 |
| Dimassi, H | 1 |
| Nasr, J | 1 |
| Harb, R | 1 |
| Mahdi, A | 1 |
| El Hout, G | 1 |
| Franjieh, E | 1 |
| Mokhbat, J | 1 |
| Farra, A | 1 |
| Husni, R | 1 |
| Day, D | 1 |
| Toh, HC | 1 |
| Ali, R | 1 |
| Foo, EMJ | 1 |
| Simes, J | 1 |
| Chia, JWK | 1 |
| Segelov, E | 1 |
| Fischer, AL | 1 |
| Messer, S | 1 |
| Riera, R | 1 |
| Martimbianco, ALC | 1 |
| Stegemann, M | 1 |
| Weibel, S | 1 |
| Monsef, I | 1 |
| Andreas, M | 1 |
| Pacheco, RL | 1 |
| Skoetz, N | 1 |
| Santos, BC | 1 |
| Flumignan, RL | 1 |
| Civile, VT | 1 |
| Atallah, ÁN | 1 |
| Nakano, LC | 1 |
| Liao, Y | 1 |
| Chi, J | 1 |
| Cheng, J | 1 |
| Wang, S | 1 |
| Li, C | 1 |
| Chen, M | 1 |
| Dalbeni, A | 1 |
| Susca, N | 1 |
| Daidone, M | 1 |
| Rossi, I | 1 |
| Giontella, A | 1 |
| Cimellaro, A | 1 |
| Talerico, G | 1 |
| Pietrangelo, A | 1 |
| Sesti, G | 1 |
| Zaccone, V | 1 |
| Villani, R | 1 |
| de Sousa, EF | 1 |
| Miele, MJ | 1 |
| Guida, JP | 1 |
| Rehder, PM | 1 |
| Surita, FG | 1 |
| Costa, ML | 1 |
| Onwuka, S | 1 |
| McIntosh, J | 1 |
| Boyd, L | 1 |
| Karnchanachari, N | 1 |
| Macrae, F | 1 |
| Fishman, G | 1 |
| Emery, J | 1 |
| Jiang, J | 1 |
| Fan, Z | 1 |
| Mao, Y | 1 |
| Kwiatkowski, S | 1 |
| Borowski, D | 1 |
| Kajdy, A | 1 |
| Poon, LC | 1 |
| Rokita, W | 1 |
| Wielgos, M | 1 |
| Gavillet, M | 1 |
| Rolnik, DL | 1 |
| Hoffman, MK | 1 |
| Panchaud, A | 1 |
| Baud, D | 1 |
| Viecca, M | 1 |
| Radovanovic, D | 1 |
| Forleo, GB | 1 |
| Santus, P | 1 |
| Rauf, A | 1 |
| Vijayan, A | 1 |
| John, ST | 1 |
| Krishnan, R | 1 |
| Latheef, A | 1 |
| Schrör, K | 1 |
| Alay, H | 1 |
| Can, FK | 1 |
| Gözgeç, E | 1 |
| Mohamed-Hussein, AAR | 1 |
| Aly, KME | 1 |
| Ibrahim, MAA | 1 |
| Berthelot, JM | 1 |
| Drouet, L | 1 |
| Lioté, F | 1 |
| Bianconi, V | 1 |
| Violi, F | 2 |
| Fallarino, F | 1 |
| Pignatelli, P | 2 |
| Sahebkar, A | 1 |
| Pirro, M | 1 |
| Lal, S | 1 |
| Hashmi, J | 1 |
| Dhanalakshmi, K | 1 |
| Venkataraman, A | 1 |
| Balasubramanian, S | 1 |
| Madhusudan, M | 1 |
| Amperayani, S | 1 |
| Putilibai, S | 1 |
| Sadasivam, K | 1 |
| Ramachandran, B | 1 |
| Ramanan, AV | 1 |
| Hodges, K | 1 |
| Mubashir, M | 1 |
| Insler, J | 1 |
| Estep, J | 1 |
| Hsich, E | 1 |
| Tong, M | 1 |
| Insler, S | 1 |
| Soltesz, E | 1 |
| Heidemann, SM | 1 |
| Tilford, B | 1 |
| Bauerfeld, C | 1 |
| Martin, A | 1 |
| Garcia, RU | 1 |
| Yagiela, L | 1 |
| Sarnaik, AP | 1 |
| Lee, WS | 1 |
| Margolskee, E | 1 |
| Mattioli, M | 1 |
| Benfaremo, D | 1 |
| Fustini, E | 1 |
| Gennarini, S | 1 |
| Trifan, G | 1 |
| Hillmann, M | 1 |
| Testai, FD | 1 |
| Florêncio, FKZ | 1 |
| Tenório, MO | 1 |
| Macedo Júnior, ARA | 1 |
| Lima, SG | 1 |
| Pavoni, V | 1 |
| Gianesello, L | 1 |
| Pazzi, M | 1 |
| Stera, C | 1 |
| Meconi, T | 1 |
| Frigieri, FC | 1 |
| Kofman, AD | 1 |
| Sizemore, EK | 1 |
| Detelich, JF | 1 |
| Albrecht, B | 1 |
| Piantadosi, AL | 1 |
| Fernández-González, SM | 1 |
| Varela-Ferreiro, N | 1 |
| Castro Aguiar, S | 1 |
| Pardo-Vázquez, JJ | 1 |
| Haque, S | 1 |
| Jawed, A | 1 |
| Akhter, N | 1 |
| Dar, SA | 1 |
| Khan, F | 1 |
| Mandal, RK | 1 |
| Areeshi, MY | 1 |
| Lohani, M | 1 |
| Wahid, M | 1 |
| Dove, ML | 1 |
| Jaggi, P | 1 |
| Kelleman, M | 1 |
| Abuali, M | 1 |
| Ang, JY | 1 |
| Ballan, W | 1 |
| Basu, SK | 1 |
| Campbell, MJ | 1 |
| Chikkabyrappa, SM | 1 |
| Choueiter, NF | 1 |
| Clouser, KN | 1 |
| Corwin, D | 1 |
| Edwards, A | 1 |
| Gertz, SJ | 1 |
| Ghassemzadeh, R | 1 |
| Jarrah, RJ | 1 |
| Katz, SE | 1 |
| Knutson, SM | 1 |
| Kuebler, JD | 1 |
| Lighter, J | 1 |
| Mikesell, C | 1 |
| Mongkolrattanothai, K | 1 |
| Morton, T | 1 |
| Nakra, NA | 1 |
| Olivero, R | 1 |
| Osborne, CM | 1 |
| Panesar, LE | 1 |
| Parsons, S | 1 |
| Patel, RM | 1 |
| Schuette, J | 1 |
| Thacker, D | 1 |
| Tremoulet, AH | 1 |
| Vidwan, NK | 1 |
| Oster, ME | 1 |
| Kethireddy, S | 1 |
| Yamane, D | 1 |
| Levine, A | 1 |
| McCurdy, MT | 1 |
| Tabatabai, A | 1 |
| Kumar, G | 1 |
| Park, P | 1 |
| Benjenk, I | 1 |
| Menaker, J | 1 |
| Ahmed, N | 1 |
| Glidewell, E | 1 |
| Presutto, E | 1 |
| Cain, S | 1 |
| Haridasa, N | 1 |
| Field, W | 1 |
| Fowler, JG | 1 |
| Trinh, D | 1 |
| Johnson, KN | 1 |
| Kaur, A | 1 |
| Lee, A | 1 |
| Sebastian, K | 1 |
| Ulrich, A | 1 |
| Peña, S | 1 |
| Carpenter, R | 1 |
| Sudhakar, S | 1 |
| Uppal, P | 1 |
| Fedeles, BT | 1 |
| Sachs, A | 1 |
| Dahbour, L | 1 |
| Teeter, W | 1 |
| Tanaka, K | 1 |
| Galvagno, SM | 1 |
| Herr, DL | 1 |
| Scalea, TM | 1 |
| Wang, N | 1 |
| Zhang, M | 2 |
| Su, H | 1 |
| Huang, Z | 1 |
| Lin, Y | 1 |
| Ghati, N | 1 |
| Roy, A | 1 |
| Bhatnagar, S | 1 |
| Bhati, S | 1 |
| Bhushan, S | 1 |
| Mahendran, M | 1 |
| Thakur, A | 1 |
| Tiwari, P | 1 |
| Dwivedi, T | 1 |
| Mani, K | 1 |
| Gupta, R | 1 |
| Mohan, A | 1 |
| Garg, R | 1 |
| Saxena, A | 1 |
| Guleria, R | 1 |
| Deepti, S | 1 |
| Yang, Y | 1 |
| Qidwai, U | 1 |
| Burton, BJL | 1 |
| Canepa, C | 1 |
| Tabaac, S | 1 |
| Kothari, P | 1 |
| Cassidy-Smith, T | 1 |
| Makiello, P | 1 |
| Svirpliene, S | 1 |
| Finlay, L | 1 |
| McKnight, J | 1 |
| Blink, M | 1 |
| Buddingh', EP | 1 |
| Filippini, LHPM | 1 |
| Brinkman, DMC | 1 |
| Joosten, SA | 1 |
| Klein, RH | 1 |
| Yuan, S | 1 |
| Chen, P | 1 |
| Li, H | 1 |
| Chen, C | 1 |
| Wang, F | 1 |
| Wang, DW | 1 |
| Giorgi-Pierfranceschi, M | 1 |
| Fu, B | 1 |
| Chen, Y | 1 |
| Li, P | 1 |
| Conde-Cardona, G | 1 |
| Contreras-Puentes, N | 1 |
| Polo-Martínez, M | 1 |
| Salah, HM | 1 |
| Meizlish, ML | 1 |
| Goshua, G | 1 |
| Liu, Y | 2 |
| Fine, R | 1 |
| Amin, K | 1 |
| Chang, E | 1 |
| DeFilippo, N | 1 |
| Keating, C | 1 |
| Mankbadi, M | 1 |
| McManus, D | 1 |
| Wang, SY | 1 |
| Price, C | 1 |
| Bona, RD | 1 |
| Ochoa Chaar, CI | 1 |
| Chun, HJ | 1 |
| Pine, AB | 1 |
| Rinder, HM | 1 |
| Siner, JM | 1 |
| Neuberg, DS | 1 |
| Owusu, KA | 1 |
| Lee, AI | 1 |
| Coppola, S | 1 |
| Chiumello, D | 1 |
| Cherqaoui, B | 1 |
| Koné-Paut, I | 1 |
| Yager, H | 1 |
| Bourgeois, FL | 1 |
| Piram, M | 1 |
| Rayamajhi, A | 1 |
| Sharma, M | 1 |
| Deo, MK | 1 |
| Shrestha, S | 1 |
| Bista, KP | 1 |
| Paudel, KP | 1 |
| Macciò, A | 1 |
| Oppi, S | 1 |
| Madeddu, C | 1 |
| Osborne, TF | 1 |
| Veigulis, ZP | 1 |
| Arreola, DM | 1 |
| Mahajan, SM | 1 |
| Röösli, E | 1 |
| Curtin, CM | 1 |
| Kevorkian, JP | 1 |
| Lopes, A | 1 |
| Sène, D | 1 |
| Riveline, JP | 1 |
| Vandiedonck, C | 1 |
| Féron, F | 1 |
| Nassarmadji, K | 1 |
| Mouly, S | 1 |
| Mauvais-Jarvis, F | 1 |
| Gautier, JF | 1 |
| Mégarbane, B | 1 |
| Liu, Q | 1 |
| Huang, N | 1 |
| Li, A | 1 |
| Liang, L | 1 |
| Song, X | 1 |
| Yang, Z | 1 |
| Zhou, X | 1 |
| Karruli, A | 1 |
| Boccia, F | 1 |
| Gagliardi, M | 1 |
| Patauner, F | 1 |
| Ursi, MP | 1 |
| Sommese, P | 1 |
| De Rosa, R | 1 |
| Murino, P | 1 |
| Ruocco, G | 1 |
| Corcione, A | 1 |
| Andini, R | 1 |
| Zampino, R | 1 |
| Durante-Mangoni, E | 1 |
| Merzon, E | 1 |
| Green, I | 1 |
| Vinker, S | 1 |
| Golan-Cohen, A | 1 |
| Gorohovski, A | 1 |
| Avramovich, E | 1 |
| Frenkel-Morgenstern, M | 1 |
| Magen, E | 1 |
| Itsekson Hayosh, Z | 1 |
| Schwammenthal, Y | 1 |
| Orion, D | 1 |
| Cattalini, M | 1 |
| Della Paolera, S | 1 |
| Zunica, F | 1 |
| Bracaglia, C | 1 |
| Giangreco, M | 1 |
| Verdoni, L | 1 |
| Meini, A | 1 |
| Sottile, R | 1 |
| Caorsi, R | 1 |
| Zuccotti, G | 1 |
| Fabi, M | 1 |
| Montin, D | 1 |
| Meneghel, A | 1 |
| Consolaro, A | 1 |
| Dellepiane, RM | 1 |
| Maggio, MC | 1 |
| La Torre, F | 1 |
| Marchesi, A | 1 |
| Simonini, G | 1 |
| Villani, A | 1 |
| Cimaz, R | 1 |
| Ravelli, A | 1 |
| Taddio, A | 1 |
| Rout, A | 1 |
| Rapista, N | 1 |
| Walia, N | 1 |
| Chaudhary, R | 1 |
| Ens, G | 1 |
| Traianova, M | 1 |
| Barnes, JS | 1 |
| Sayed Ahmed, HA | 2 |
| Merrell, E | 2 |
| Ismail, M | 1 |
| Joudeh, AI | 1 |
| Riley, JB | 2 |
| Shawkat, A | 1 |
| Habeb, H | 1 |
| Darling, E | 2 |
| Goweda, RA | 1 |
| Shehata, MH | 1 |
| Amin, H | 2 |
| Nieman, GF | 2 |
| Aiash, H | 2 |
| Chiang, KC | 1 |
| Gupta, A | 2 |
| Siegel, AJ | 1 |
| Mansoor, T | 1 |
| Alsarah, AA | 1 |
| Mousavi, H | 1 |
| Khader Eliyas, J | 1 |
| Girotra, T | 1 |
| Hussein, O | 1 |
| Haji Aghajani, M | 1 |
| Moradi, O | 1 |
| Amini, H | 1 |
| Azhdari Tehrani, H | 1 |
| Pourheidar, E | 1 |
| Rabiei, MM | 1 |
| Sistanizad, M | 1 |
| Kok, EY | 1 |
| Srivaths, L | 1 |
| Grimes, AB | 1 |
| Vogel, TP | 1 |
| Sexson Tejtel, SK | 1 |
| Muscal, E | 1 |
| White, AA | 1 |
| Cahill, KN | 1 |
| Jerschow, E | 1 |
| Kuruvilla, M | 1 |
| Sehanobish, E | 1 |
| Bensko, J | 1 |
| Laidlaw, TM | 2 |
| Levy, JM | 1 |
| Kinter, CW | 1 |
| Saxon, GE | 1 |
| Ahmad, M | 1 |
| Berhane, H | 1 |
| Gensler, L | 1 |
| Khosroshahi, A | 1 |
| Buchheit, KM | 1 |
| Hacker, JJ | 1 |
| Gakpo, DH | 1 |
| Mullur, J | 1 |
| Sohail, A | 1 |
| Martha, JW | 1 |
| Pranata, R | 1 |
| Lim, MA | 1 |
| Wibowo, A | 1 |
| Akbar, MR | 1 |
| Sahai, A | 1 |
| Bhandari, R | 1 |
| Godwin, M | 1 |
| McIntyre, T | 1 |
| Chung, MK | 1 |
| Iskandar, JP | 1 |
| Kamran, H | 1 |
| Hariri, E | 1 |
| Aggarwal, A | 1 |
| Burton, R | 1 |
| Kalra, A | 1 |
| Bartholomew, JR | 1 |
| McCrae, KR | 1 |
| Elbadawi, A | 1 |
| Bena, J | 1 |
| Svensson, LG | 1 |
| Kapadia, S | 1 |
| Cameron, SJ | 1 |
| Venkatesh, R | 1 |
| Reddy, NG | 1 |
| Agrawal, S | 1 |
| Pereira, A | 1 |
| Cammisotto, V | 1 |
| Gottlieb, M | 1 |
| Bridwell, R | 1 |
| Ravera, J | 1 |
| Long, B | 1 |
| Srivastava, R | 1 |
| Kumar, A | 1 |
| D'Angelo, T | 1 |
| Cattafi, A | 1 |
| Carerj, ML | 1 |
| Booz, C | 1 |
| Ascenti, G | 1 |
| Cicero, G | 1 |
| Blandino, A | 1 |
| Mazziotti, S | 1 |
| Rizk, JG | 1 |
| Lavie, CJ | 1 |
| Senthilnathan, M | 1 |
| Ravi, R | 1 |
| Sivakumar, RK | 1 |
| Majella, MG | 1 |
| Chidambaram, V | 1 |
| Mura, C | 1 |
| Preissner, S | 1 |
| Nahles, S | 1 |
| Heiland, M | 1 |
| Bourne, PE | 1 |
| Preissner, R | 1 |
| Sharma, A | 1 |
| Sharma, C | 1 |
| Raina, S | 1 |
| Singh, B | 1 |
| Dadhwal, DS | 1 |
| Dogra, V | 1 |
| Gupta, S | 1 |
| Bhandari, S | 1 |
| Sood, V | 1 |
| Abdelwahab, HW | 1 |
| Shaltout, SW | 1 |
| Fouad, AM | 1 |
| Salama, R | 1 |
| Abdelrahman, AG | 1 |
| Fadel, G | 1 |
| Elfar, MSA | 1 |
| Sabry, K | 1 |
| Mishriky, A | 1 |
| Son, M | 1 |
| Noh, MG | 1 |
| Lee, JH | 1 |
| Seo, J | 1 |
| Park, H | 1 |
| Yang, S | 1 |
| Mourad, JJ | 1 |
| Suhl, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| COVID-19 Outpatient Thrombosis Prevention Trial A Multi-center Adaptive Randomized Placebo-controlled Platform Trial Evaluating the Efficacy and Safety of Anti-thrombotic Strategies in COVID Adults Not Requiring Hospitalization at Time of Diagnosis[NCT04498273] | Phase 3 | 657 participants (Actual) | Interventional | 2020-09-07 | Terminated (stopped due to an event rate lower than anticipated) | ||
| ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial[NCT02326350] | Phase 2 | 49 participants (Actual) | Interventional | 2015-02-06 | Terminated (stopped due to Slow recruitment) | ||
| Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia[NCT02735707] | Phase 3 | 10,000 participants (Anticipated) | Interventional | 2016-04-11 | Recruiting | ||
| Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized Trial[NCT04324463] | Phase 3 | 6,667 participants (Actual) | Interventional | 2020-04-21 | Active, not recruiting | ||
| Dynamics of Hemostatic Parameters in COVID-19 and Comparison of Intervention Strategies Through Adaptive Clinical Trial[NCT04466670] | Phase 2 | 379 participants (Anticipated) | Interventional | 2020-07-11 | Recruiting | ||
| Multicenter Randomized, Double-blind, Placebo-controlled, Clinical Trial of Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients (Asperum)[NCT04808895] | Phase 3 | 204 participants (Anticipated) | Interventional | 2021-04-01 | Not yet recruiting | ||
| Retrospective Single-center Cohort Study to Evaluate the Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19 Admitted to a Large Intensive Care Unit in Milan, Italy[NCT05293418] | 435 participants (Actual) | Observational | 2020-10-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome will be a composite endpoint of need for hospitalization for cardiovascular/pulmonary events, symptomatic deep venous thrombosis, pulmonary embolism, arterial thromboembolism, myocardial infarction, ischemic stroke, and all-cause mortality for up to 45 days after initiation of assigned treatment. (NCT04498273)
Timeframe: 45 days
| Intervention | participants (Number) |
|---|---|
| Apixaban 2.5mg | 1 |
| Apixaban 5mg | 1 |
| Asprin | 0 |
| Placebo | 0 |
18 reviews available for aspirin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.
Topics: Abciximab; Acute Disease; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; COVID-19; COVID-19 | 2022 |
The effect of antithrombotic treatment on mortality in patients with acute infection: A meta-analysis of randomized clinical trials.
Topics: Anticoagulants; Aspirin; COVID-19; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topi | 2023 |
Pericarditis related to post-acute COVID infection: A case report and review of the literature.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chest Pain; Colchicine; COVID-19; Female; Humans; | 2023 |
Antiplatelet agents for the treatment of adults with COVID-19.
Topics: Adult; Aspirin; Asymptomatic Infections; COVID-19; Humans; Platelet Aggregation Inhibitors; SARS-CoV | 2023 |
Prophylactic anticoagulants for non-hospitalised people with COVID-19.
Topics: Anticoagulants; Aspirin; COVID-19; Humans; Platelet Aggregation Inhibitors; Pulmonary Embolism; Veno | 2023 |
Promising Anti-Inflammatory Tools: Biomedical Efficacy of Lipoxins and Their Synthetic Pathways.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; COVID-19; Inflammation; Lipoxins; Mammals | 2023 |
Can an Old Ally Defeat a New Enemy?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Betacoronavirus; Coronavirus Infections; | 2020 |
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Topics: Angiotensin II; Animals; Aspirin; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Dip | 2020 |
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?
Topics: Anti-Inflammatory Agents; Aspirin; Betacoronavirus; Blood Coagulation; Coronavirus Infections; COVID | 2020 |
Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; COVID-19; COVID-19 Drug Treatment; Global Health; | 2021 |
Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
Topics: Adolescent; Aspirin; C-Reactive Protein; Case-Control Studies; Child; Child, Preschool; Coronary Dis | 2021 |
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
Topics: Adrenal Cortex Hormones; Aspirin; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 | 2021 |
Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis.
Topics: Aspirin; COVID-19; COVID-19 Drug Treatment; Humans; Platelet Aggregation Inhibitors | 2021 |
Rationales and uncertainties for aspirin use in COVID-19: a narrative review.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; COVID-19; Humans; Inflammation; Middl | 2021 |
Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates.
Topics: Aspirin; COVID-19; Hospitalization; Humans; Prescriptions; SARS-CoV-2 | 2021 |
Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets.
Topics: Aspirin; Blood Platelets; COVID-19; COVID-19 Drug Treatment; Humans; Myocardial Infarction; SARS-CoV | 2021 |
Multisystem inflammatory syndrome in children with COVID-19.
Topics: Adolescent; Adrenal Cortex Hormones; Aspirin; Child; Child, Preschool; COVID-19; Emergency Service, | 2021 |
Use of aspirin in reduction of mortality of COVID-19 patients: A meta-analysis.
Topics: Aspirin; COVID-19; Humans; Respiratory Distress Syndrome; SARS-CoV-2 | 2021 |
12 trials available for aspirin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial.
Topics: Adult; Aspirin; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Double-Blind Me | 2021 |
Aspirin as a Treatment for ARDS: A Randomized, Placebo-Controlled Clinical Trial.
Topics: Adult; Aspirin; COVID-19; Double-Blind Method; Humans; Intensive Care Units; Respiration, Artificial | 2022 |
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Topics: Adult; Anticoagulants; Aspirin; Bayes Theorem; COVID-19; COVID-19 Drug Treatment; Critical Illness; | 2022 |
Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19.
Topics: Adult; Aspirin; Cohort Studies; COVID-19; Hospital Mortality; Hospitalization; Humans; Middle Aged; | 2022 |
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.
Topics: Aspirin; Canada; Colchicine; COVID-19; Disease Progression; Humans; SARS-CoV-2; Thrombosis; Treatmen | 2022 |
A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection.
Topics: Antiviral Agents; Aspirin; Aspirin, Dipyridamole Drug Combination; COVID-19; Female; Humans; SARS-Co | 2023 |
In high-risk outpatients with COVID-19, neither colchicine nor aspirin reduced disease progression or death at 45 d.
Topics: Aspirin; Colchicine; COVID-19; Disease Progression; Humans; Outpatients; Treatment Outcome | 2023 |
A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial.
Topics: Acute Coronary Syndrome; Aspirin; Bayes Theorem; COVID-19; Hemorrhage; Humans; SARS-CoV-2; Treatment | 2023 |
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.
Topics: Aged; Aspirin; Betacoronavirus; Clopidogrel; Compassionate Use Trials; Coronavirus Infections; COVID | 2020 |
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Topics: Adult; Aged; Aspirin; Atorvastatin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug | 2020 |
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis.
Topics: Adult; Aged; Anticoagulants; Aspirin; COVID-19; COVID-19 Drug Treatment; Female; Hospital Mortality; | 2021 |
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
Topics: Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controll | 2021 |
99 other studies available for aspirin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children.
Topics: Adolescent; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Child; Child, Preschool; CO | 2021 |
Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic.
Topics: Aspirin; Cardiovascular Diseases; COVID-19; Diabetes Mellitus; Humans; Pandemics; Platelet Aggregati | 2022 |
Aspirin Is Related to Worse Clinical Outcomes of COVID-19.
Topics: Aspirin; Cohort Studies; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2 | 2021 |
Myopericarditis After COVID-19 mRNA Vaccination.
Topics: Adverse Drug Reaction Reporting Systems; Aspirin; BNT162 Vaccine; C-Reactive Protein; COVID-19; Diur | 2022 |
Pre-admission acetylsalicylic acid therapy and impact on in-hospital outcome in COVID-19 patients: The ASA-CARE study.
Topics: Aged; Aspirin; Cohort Studies; COVID-19; Hospital Mortality; Hospitalization; Hospitals; Humans; Mal | 2021 |
Does aspirin save lives in patients with COVID-19?
Topics: Aspirin; COVID-19; Health Personnel; Humans; SARS-CoV-2 | 2022 |
Further evidence for the use of aspirin in COVID-19.
Topics: Aspirin; COVID-19; Humans; SARS-CoV-2 | 2022 |
Synthesis of aspirin-curcumin mimic conjugates of potential antitumor and anti-SARS-CoV-2 properties.
Topics: Antineoplastic Agents; Antiviral Agents; Aspirin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Sur | 2021 |
Is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?
Topics: Aspirin; COVID-19; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Risk F | 2022 |
Concurrent Cerebral, Splenic, and Renal Infarction in a Patient With COVID-19 Infection.
Topics: Anticoagulants; Aspirin; COVID-19; Humans; Infarction; Male; Middle Aged; Stroke; Thrombosis | 2022 |
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2
Topics: Aged; Aged, 80 and over; Aspirin; Betamethasone; Cohort Studies; COVID-19; COVID-19 Drug Treatment; | 2021 |
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-
Topics: Aspirin; COVID-19; Humans; Pre-Eclampsia; Risk Factors; SARS-CoV-2 | 2022 |
Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia.
Topics: Aged; Aged, 80 and over; Aspirin; Cohort Studies; COVID-19; Humans; Inpatients; Pneumonia; Retrospec | 2022 |
Beneficial Effect of Low Dose Aspirin in Adult Patients with COVID-19: A Retrospective Observational Study in Bangladesh.
Topics: Adult; Aspirin; Bangladesh; Child; COVID-19; Humans; SARS-CoV-2; Thrombosis | 2022 |
The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization.
Topics: Adolescent; Anticoagulants; Ascorbic Acid; Aspirin; Calcium; COVID-19; Cross-Sectional Studies; Diet | 2022 |
Aspirin use Reduces Platelet Hyperreactivity and Degranulation in COVID-19 Patients.
Topics: Aspirin; Blood Platelets; COVID-19; Humans; Platelet Activation; Platelet Aggregation; Platelet Aggr | 2023 |
Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
Topics: Adult; Aspirin; COVID-19; Critical Illness; Hemorrhage; Humans; Intensive Care Units; Propensity Sco | 2022 |
Dual antiplatelet use in the management of COVID-19 associated acute ischemic stroke reocclusion.
Topics: Aspirin; Brain Ischemia; COVID-19; Humans; Ischemic Stroke; Middle Aged; Retrospective Studies; SARS | 2023 |
Decreased mortality in coronavirus disease 2019 associated mucormycosis with aspirin use: a retrospective cohort study.
Topics: Antifungal Agents; Aspirin; COVID-19; Debridement; Humans; Mucormycosis; Orbital Diseases; Retrospec | 2022 |
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry.
Topics: Anticoagulants; Aspirin; Cohort Studies; COVID-19; Humans; Propensity Score; Registries; Retrospecti | 2022 |
Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies?
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; COVID-19; Enoxaparin; Humans; Manni | 2022 |
The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study.
Topics: Anticoagulants; Aspirin; COVID-19; Critical Illness; Hemorrhage; Heparin, Low-Molecular-Weight; Huma | 2022 |
Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS).
Topics: Adult; Aspirin; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Male; Pandemics; SARS | 2022 |
COVID-19 outcomes in patients taking cardioprotective medications.
Topics: Aspirin; COVID-19; COVID-19 Drug Treatment; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reduc | 2022 |
The First Year of the COVID-19 Pandemic: Changes in Preventive Services in Community Health Centers.
Topics: Aspirin; Colorectal Neoplasms; Community Health Centers; COVID-19; Early Detection of Cancer; Female | 2023 |
[Antiplatelet drugs and COVID-19: use for prevention of arterial vascular complications in different time periods of the disease].
Topics: Arteries; Aspirin; COVID-19; Humans; Platelet Aggregation Inhibitors; Russia | 2021 |
Response to Aspirin Therapy in COVID-19: Prevention of NETosis.
Topics: Analgesics; Aspirin; COVID-19; Humans | 2023 |
Aspirin and P2Y12 inhibitors in treating COVID-19.
Topics: Aspirin; Blood Platelets; COVID-19; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor | 2023 |
Aspirin and P2Y12 inhibitors in treating COVID-19.
Topics: Aspirin; Blood Platelets; COVID-19; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor | 2023 |
Aspirin and P2Y12 inhibitors in treating COVID-19.
Topics: Aspirin; Blood Platelets; COVID-19; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor | 2023 |
Aspirin and P2Y12 inhibitors in treating COVID-19.
Topics: Aspirin; Blood Platelets; COVID-19; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor | 2023 |
Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis.
Topics: Aspirin; Cohort Studies; COVID-19; Hospital Mortality; Humans; Pulmonary Disease, Chronic Obstructiv | 2022 |
The Effectiveness of Antiplatelet Therapy and the Factors Influencing It in Patients with Acute Coronary Syndrome before and during the COVID-19 Pandemic.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Clopidogrel; COVID-19; Drug Therapy, Combination; Human | 2022 |
IL1RA mediated the effects of aspirin on COVID-19 severity: A Mendelian randomization study.
Topics: Aspirin; COVID-19; Humans; Mendelian Randomization Analysis; Polymorphism, Single Nucleotide; Recept | 2023 |
Comment on 'The dangers of non-randomized, observational studies. Experience from the COVID-19 epidemic'. Aspirin therapy in COVID-19: too soon to dismiss its benefits?
Topics: Aspirin; COVID-19; Epidemics; Humans | 2023 |
Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemic.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Antipyretics; Aspirin; Child; Child, Preschool; | 2023 |
Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2.
Topics: Adenoviridae; Aspirin; Blood Platelets; BNT162 Vaccine; ChAdOx1 nCoV-19; COVID-19; COVID-19 Vaccines | 2023 |
Synchronous spectrofluorimetric determination of favipiravir and aspirin at the nano-gram scale in spiked human plasma; greenness evaluation.
Topics: Aspirin; COVID-19; COVID-19 Drug Treatment; Ethanol; Humans; Spectrometry, Fluorescence | 2023 |
The use of analgesics for intentional self-poisoning: Trends in U.S. poison center data.
Topics: Acetaminophen; Adolescent; Adult; Analgesics; Aspirin; Child; COVID-19; Female; Humans; Ibuprofen; M | 2023 |
Effect of combination of prophylactic or therapeutic anticoagulation with aspirin on the outcomes of hospitalized COVID-19 patients: An observational retrospective study.
Topics: Anticoagulants; Aspirin; Blood Coagulation; COVID-19; Humans; Retrospective Studies; SARS-CoV-2 | 2023 |
Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial.
Topics: Asia; Aspirin; Colorectal Neoplasms; COVID-19; Humans; Pandemics | 2023 |
Identification of potential new COVID-19 treatments via RWD-driven drug repurposing.
Topics: Aspirin; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Drug Repositioning; Humans | 2023 |
Low dose aspirin and clinical outcomes in patients with SARS-CoV-2 pneumonia: a propensity score-matched cohort analysis from the National SIMI‑COVID‑19 Registry.
Topics: Aged; Aged, 80 and over; Aspirin; Cohort Studies; COVID-19; Female; Humans; Male; Multicenter Studie | 2023 |
Nutricional intake, maternal outcomes and knowledge on preeclampsia prevention: Was there impact during the COVID-19 pandemic among women with hypertension?
Topics: Adult; Aspirin; Calcium; COVID-19; Female; Humans; Hypertension; Pandemics; Pre-Eclampsia; Pregnancy | 2023 |
Should I take aspirin? A qualitative study on the implementation of a decision aid on taking aspirin for bowel cancer prevention.
Topics: Aspirin; Australia; Colorectal Neoplasms; COVID-19; Decision Support Techniques; Humans; Pandemics | 2023 |
A case of multisystem inflammatory syndrome in children: A case report.
Topics: Aspirin; Child; Child, Preschool; Connective Tissue Diseases; COVID-19; Female; Humans; Mucocutaneou | 2023 |
Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic.
Topics: Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Infant; Infant, Newborn; | 2020 |
Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
Topics: Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Pandemics; Pneumonia, Vi | 2020 |
Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic.
Topics: Aspirin; Child, Preschool; Coronavirus Infections; COVID-19; Diagnosis, Differential; Humans; Immuno | 2020 |
Cerebral Infarction in an Elderly Patient with Coronavirus Disease.
Topics: Aged, 80 and over; Anticoagulants; Aspirin; Betacoronavirus; Cerebral Infarction; Coronavirus; Coron | 2020 |
Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Autopsy; Blood Coagulation Disorde | 2020 |
A Rare Finding of Upper Limb Deep Venous Thrombosis in a Patient with COVID-19.
Topics: Anticoagulants; Arm; Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Edema; Enoxaparin; | 2020 |
Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
Topics: Adolescent; Antibodies, Monoclonal, Humanized; Aspirin; Blood Coagulation Disorders; C-Reactive Prot | 2020 |
Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device.
Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Blood Transfusion; COVID-19; Cytokine Release Syndrome; | 2020 |
Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2.
Topics: Antipyretics; Aspirin; Betacoronavirus; Child; Child, Preschool; Conjunctivitis; Coronavirus Infecti | 2020 |
Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.
Topics: Anti-Inflammatory Agents; Aspirin; Betacoronavirus; Child; Clinical Laboratory Techniques; Coronavir | 2020 |
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19).
Topics: Aged, 80 and over; Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Erythrocyte Transfusi | 2020 |
Acute Stroke as the Presenting Symptom of SARS-CoV-2 Infection in a Young Patient with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.
Topics: Adult; Aspirin; Betacoronavirus; CADASIL; Coronavirus Infections; COVID-19; Female; Host-Pathogen In | 2020 |
Aspirin with or without statin in the treatment of endotheliitis, thrombosis, and ischemia in coronavirus disease.
Topics: Aspirin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; En | 2020 |
Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
Topics: Adult; Aged; Anticoagulants; Aspirin; COVID-19; Critical Illness; Female; Hemorrhage; Heparin, Low-M | 2020 |
A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report.
Topics: Adult; Aspirin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; D | 2020 |
SARS-CoV-2 infection as trigger multisystem inflammatory syndrome?
Topics: Aspirin; Child, Preschool; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Fa | 2021 |
Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism.
Topics: Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Platelet Aggregation | 2020 |
Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antirheumatic Agents; Aspirin; Child; Clini | 2021 |
Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019.
Topics: Adult; Aged; Aspirin; COVID-19; Female; Fibrinolytic Agents; Hospital Mortality; Humans; Intensive C | 2021 |
Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic.
Topics: Aged; Aspirin; Clopidogrel; Coronavirus Infections; COVID-19; Female; Fibrinolysis; Fibrinolytic Age | 2020 |
Bilateral, vertical supranuclear gaze palsy following unilateral midbrain infarct.
Topics: Aspirin; Atrial Fibrillation; Betacoronavirus; Blindness; Brain Stem Infarctions; Coronavirus Infect | 2020 |
Multisystem Inflammatory Syndrome in Children.
Topics: Aspirin; Child; COVID-19; COVID-19 Drug Treatment; Humans; Immunoglobulins; Male; SARS-CoV-2; System | 2021 |
Paediatric inflammatory multisystem syndrome temporally associated with COVID-19: a new virus and a new case presentation.
Topics: Adrenal Cortex Hormones; Aspirin; Child; COVID-19; COVID-19 Drug Treatment; Humans; Immunoglobulins, | 2020 |
[COVID-19-associated hyperinflammatory state in a 15-year-old female patient].
Topics: Adolescent; Anti-Inflammatory Agents; Aspirin; Cardiotonic Agents; COVID-19; COVID-19 Serological Te | 2020 |
Mortality and pre-hospitalization use of low-dose aspirin in COVID-19 patients with coronary artery disease.
Topics: Aged; Aspirin; China; Coronary Artery Disease; COVID-19; Female; Hospital Mortality; Hospitalization | 2021 |
Is Aspirin Effective in Preventing Intensive Care Unit Admission in Patients With Coronavirus Disease 2019 Pneumonia?
Topics: Aspirin; COVID-19; Hospital Mortality; Humans; Intensive Care Units; Pneumonia; Respiration, Artific | 2021 |
2019 novel coronavirus disease with secondary ischemic stroke: two case reports.
Topics: Aspirin; Atorvastatin; Brain Ischemia; COVID-19; Fibrinolytic Agents; Humans; Ischemic Stroke; Male; | 2021 |
[Remembering Reye's Syndrome in times of COVID-19].
Topics: Adult; Aspirin; COVID-19; Humans; Reye Syndrome; SARS-CoV-2 | 2020 |
Aspirin in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome: An Old, Low-Cost Therapy With a Strong Rationale.
Topics: Aspirin; COVID-19; Hospital Mortality; Humans; Intensive Care Units; Respiration, Artificial; Respir | 2021 |
Kawasaki Disease like Multisystem Inflammatory Syndrome in a Toddler during SARS-CoV-2 Pandemic in Nepal.
Topics: Aspirin; COVID-19; COVID-19 Drug Treatment; Humans; Immunoglobulins; Infant; Male; Nepal; Systemic I | 2021 |
Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; COVID-19; COVID-19 Drug Treatment; Fe | 2021 |
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.
Topics: Adrenal Cortex Hormones; Anticoagulants; Aspirin; Cohort Studies; Colchicine; COVID-19; Furosemide; | 2021 |
Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19.
Topics: Adult; Aged; Aspirin; China; COVID-19; COVID-19 Drug Treatment; Embolism; Female; Fibrinolytic Agent | 2021 |
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Aspirin; Carb | 2021 |
The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID-19 infection.
Topics: Adult; Aged; Aspirin; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus; | 2021 |
Can other coronavirus infections cause a cryptogenic stroke in a young patient?
Topics: Acyclovir; Antiviral Agents; Aspirin; Coronavirus Infections; Coronavirus OC43, Human; COVID-19; Hum | 2021 |
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
Topics: Age Distribution; Antirheumatic Agents; Aspirin; C-Reactive Protein; Child; Child, Preschool; Corona | 2021 |
Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population.
Topics: Anticoagulants; Aspirin; Biological Availability; Biomarkers, Pharmacological; Black or African Amer | 2021 |
In Response.
Topics: Aspirin; COVID-19; Hospital Mortality; Humans; Intensive Care Units; Respiration, Artificial; SARS-C | 2021 |
Aspirin Resistance in Obese and Elderly Patients with COVID-19?
Topics: Aged; Aspirin; COVID-19; Humans; Obesity; Outpatients; SARS-CoV-2 | 2021 |
Aspirin Use for Primary Cardiovascular Prevention During the COVID-19 Pandemic.
Topics: Aspirin; Cardiovascular Diseases; COVID-19; Humans; Pandemics; Primary Prevention; Regression Analys | 2021 |
COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin.
Topics: Adult; Aspirin; Cerebral Arteries; COVID-19; Female; Humans; Nimodipine; Syndrome; Treatment Outcome | 2021 |
Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Aspirin; Blood Platelets; Coronary | 2021 |
Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; COVID-19; Disease Management; Glucocorticoi | 2021 |
COVID-19 in a series of patients with aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; COVID-19; Humans; Respira | 2021 |
Multisystem inflammatory syndrome in an adult with involvement of the skin, lymph nodes, muscle, heart, liver and kidneys.
Topics: Acute Kidney Injury; Adult; Anti-Inflammatory Agents; Aspirin; Asymptomatic Infections; Biomarkers; | 2021 |
Influence of daily aspirin therapy on ACE2 expression and function-implications for SARS-CoV-2 and patients with aspirin-exacerbated respiratory disease.
Topics: Adult; Angiotensin-Converting Enzyme 2; Aspirin; COVID-19; COVID-19 Drug Treatment; Female; Gene Exp | 2021 |
Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; COVID-19; Female; Hospitalization; Hu | 2021 |
COVID-19-associated central retinal vein occlusion treated with oral aspirin.
Topics: Aspirin; COVID-19; Female; Fluorescein Angiography; Humans; Middle Aged; Retinal Vein Occlusion; SAR | 2021 |
Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction?
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Inflammatory Agents; Aspirin; Bisoprolol; BNT162 | 2021 |
Low-dose aspirin for early COVID-19: does the early bird catch the worm?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; COVID-19; COVID-19 Drug Treatment; Dose-Response R | 2021 |
Aspirin Use, Mechanical Ventilation, and Inhospital Mortality in Coronavirus Disease 2019: Are We Missing Something?
Topics: Aspirin; COVID-19; Hospital Mortality; Humans; Respiration, Artificial; Retrospective Studies; SARS- | 2021 |
Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.
Topics: Aspirin; COVID-19; Histamine Antagonists; Histamine H2 Antagonists; Humans; SARS-CoV-2 | 2021 |
Acetylsalicylic Acid Compared with Enoxaparin for the Prevention of Thrombosis and Mechanical Ventilation in COVID-19 Patients: A Retrospective Cohort Study.
Topics: Anticoagulants; Aspirin; COVID-19; Enoxaparin; Humans; Respiration, Artificial; Retrospective Studie | 2021 |
Effect of aspirin on coronavirus disease 2019: A nationwide case-control study in South Korea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studi | 2021 |
Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; COVID-19; Humans; Platelet Aggregation Inhibitors; | 2021 |